Active substance
Lindane
- SFDA 3
- US FDA 14
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| KWELL CREAM | 1 % | Cream · Topical | 1 Bottle | SAR 12.00 | NCE · OTC | RED AND CARNIK | Invalid · Not Marketed |
| KWELL LOTION | 1 % | Solution · Topical | 1 Bottle | SAR 10.90 | NCE · OTC | RED AND CARNIK | Invalid · Not Marketed |
| KWELL SHAMPOO | 1 % | Shampoo · Topical | 1 Bottle | SAR 11.45 | NCE · OTC | RED AND CARNIK | Invalid · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| KWELL | 1% | cream · topical | REED AND CARNRICK | Discontinued | 19 Dec 1974 |
| KWELL | 1% | lotion · topical | REED AND CARNRICK | Discontinued | 19 Dec 1974 |
| KWELL | 1% | shampoo · topical | REED AND CARNRICK | Discontinued | 22 Jan 1975 |
| GAMENE | 1% | shampoo · topical | SOLA BARNES HIND | Discontinued | 15 Jun 1976 |
| GAMENE | 1% | lotion · topical | SOLA BARNES HIND | Discontinued | 15 Jun 1976 |
| LINDANE | 1% | shampoo · topical | OLTA PHARMS | Discontinued | 17 Dec 1981 |
| LINDANE | 1% | lotion · topical | OLTA PHARMS | Discontinued | 17 Dec 1981 |
| LINDANE | 1% | lotion · topical | WOCKHARDT BIO AG | Discontinued | 16 Aug 1984 |
| LINDANE | 1% | shampoo · topical | WOCKHARDT BIO AG | Discontinued | 18 Sep 1984 |
| SCABENE | 1% | lotion · topical | STIEFEL | Discontinued | |
| SCABENE | 1% | shampoo · topical | STIEFEL | Discontinued | |
| KWELL | 1% | cream · topical | REED AND CARNRICK | Discontinued | |
| KWELL | 1% | lotion · topical | REED AND CARNRICK | Discontinued | |
| KWELL | 1% | shampoo · topical | REED AND CARNRICK | Discontinued |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.